Publication & Citation Trends
Most Cited Works
Publications
6 total
A SARS-CoV-2 recombinant spike protein vaccine (S-268019-b) for COVID-19 prevention during the Omicron-dominant period: A phase 3, randomised, placebo-controlled clinical trial PDF
Cited by 4
OpenAlex
Safety and immunogenicity of a booster dose of S-268019-b: Interim findings of a Phase 3, open-label clinical study in Japan PDF
Cited by 5
OpenAlex
Immunogenicity and safety of booster dose of S-268019-b or BNT162b2 in Japanese participants: An interim report of phase 2/3, randomized, observer-blinded, noninferiority study PDF
Cited by 21
OpenAlex
Phase 1/2 clinical trial of COVID-19 vaccine in Japanese participants: A report of interim findings PDF
Cited by 20
OpenAlex
Research Topics
SARS-CoV-2 and COVID-19 Research
(6)
COVID-19 Clinical Research Studies
(2)
Viral Infections and Immunology Research
(2)
vaccines and immunoinformatics approaches
(2)
Influenza Virus Research Studies
(1)
Frequent Co-Authors
Affiliations
Shionogi (Japan)
Futaba (Japan)